Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Ms Sushma Shankar from the Nuffield Department of Surgical Sciences (NDS) who has been recruited to the Royal College of Surgeons of England 2025 Emerging Leaders programme.

Sushma Shanka


The Emerging Leaders programme is open to women and non-binary individuals looking to grow their skills and influence change as they move into leadership roles. It offers participants an opportunity to develop their leadership behaviours, create networks and overcome challenges faced by women and non-binary people.

Following a competitive process, Ms Shankar, who is Senior Clinical Research Fellow and Honorary Consultant Surgeon in Transplantation within the Translational Research Immunology Group at NDS, was chosen for the 2025 Emerging Leaders cohort. The programme runs for 23 months, starting in February and finishing in December of next year.

Ms Shankar said: ‘It’s an honour to have been selected for the RCS Emerging Leaders programme. I am really looking forward to developing different skills whilst making the most of the opportunities presented by this fellowship. Female surgeons remain underrepresented in leadership. It can sometimes be challenging to be the outlier in the room and even more so to try and do something about that. I appreciate change will not occur unless we step up and forward.’

Find out more about the Emerging Leaders programme on the Royal College of Surgeons of England's website.

 

Read the news story on the Nuffield Department of Surgical Sciences website.

 

 

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.